Jennifer Cote
CIK 1960481 · View on SEC EDGAR ↗
First SEC filing: Jan. 3, 2023 · Latest: Jan. 3, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 19, 2025 | HBIO | F | 5,687 | $0.69 | $3,924 | 159,019 Direct | -3.45% | Disposed | 4.3% (price as of 2026-08-20) |
| Dec. 29, 2024 | HBIO | F | 3,797 | $1.98 | $7,518 | 160,210 Direct | -2.32% | Disposed | -63.6% (price as of 2026-08-20) |
| Dec. 29, 2024 | HBIO | F | 4,731 | $1.98 | $9,367 | 164,007 Direct | -2.80% | Disposed | -63.6% (price as of 2026-08-20) |
| March 6, 2024 | HBIO | F | 9,920 | $4.11 | $40,771 | 168,738 Direct | -5.55% | Disposed | -82.5% (price as of 2026-08-20) |
| March 5, 2024 | HBIO | A | 35,800 | — | — | 178,658 Direct | +25.06% | Acquired | (price as of 2026-08-20) |
| March 5, 2024 | HBIO | A | 35,800 | — | — | 142,858 Direct | +33.44% | Acquired | (price as of 2026-08-20) |
| Dec. 29, 2023 | HBIO | F | 2,631 | $5.35 | $14,076 | 107,058 Direct | -2.40% | Disposed | -86.5% (price as of 2026-08-20) |
| Dec. 29, 2023 | HBIO | F | 3,279 | $5.35 | $17,543 | 109,689 Direct | -2.90% | Disposed | -86.5% (price as of 2026-08-20) |
| March 6, 2023 | HBIO | A | 29,880 | — | — | 112,968 Direct | +35.96% | Acquired | (price as of 2026-08-20) |
| March 6, 2023 | HBIO | A | 25,862 | — | — | 83,088 Direct | +45.19% | Acquired | (price as of 2026-08-20) |
| March 6, 2023 | HBIO | A | 26,892 | — | — | 57,226 Direct | +88.65% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 3, 2023 | HBIO | Common Stock | 30,334 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $118,846 | — | — | — | — | — | $4,160 | $123,006 |
| 2024 | $293,654 | — | $300,000 | — | — | — | $8,947 | $602,601 |
| 2023 | $285,789 | $67,500 | $210,000 | — | — | — | $7,983 | $571,272 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.